Steven Fein, MD, specializes in hematology oncology and is board certified in internal medicine, medical oncology, hematology, and hospice and palliative medicine by the American Board of Internal Medicine. He practices at University of Pittsburgh Physicians, Department of Hematology Oncology. Dr. Fein completed his fellowship at University of Miami Miller School of Medicine at Jackson Memorial Hospital, residency at Duke University Medical Center, and medical education at Johns Hopkins University School of Medicine. Dr. Fein is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Bone Marrow Aspiration, and Splenectomy.

Roy E. Smith, MD, is a professor of medicine at the University of Pittsburgh School of Medicine in the Division of Hematology/Oncology. Dr Smith specializes in bleeding and thrombotic disorders, Rare Homologic Diseases, Chronic Leukemia and Myelodyplasia. Dr. Smith is board-certified in internal medicine, medical oncology, and hematology. He received his medical degree from The Ohio State University, Columbus, and his Master of Science degree from the University of Wisconsin, College of Medicine, Madison. He completed his residency in medical oncology and his fellowship in hematology oncology, both at The Ohio State University. He is the former director of the Ohio State University Hospital's Special Coagulation Laboratory and its Hemophilia Center. He presently serves as chairman of the Central Investigational Review Board for the Cancer Therapeutics and Development branch of the National Cancer Institute and has served on the Peripheral and Central Nervous System Drug Advisory Committee and the Oncologic Drug Advisory Committee of the FDA. Dr. Smith serves as the co-chair of the Anticoagulation Task Force for the Presbyterian Hospital and its affiliates and chair of the Anticoagulation Working Group of the system-wide P and T committee. Dr. Smith is a member of the American Society of Hematology, the American Society of Clinical Oncology, the Society for Scientific Exploration, The International Society of Thrombosis and Hemostasis, the American Medical Association and the American Society for Apheresis, and the American College of Chest Physicians. He is a Fellow of the American College of Physicians and the International Academy of Clinical and Applied Thrombosis and Hemostasis. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Venous Thromboembolism (VTE), Acute Hepatic Porphyria (AHP), Shwartzman Phenomenon, and Porphyria.

Georgia Vasilakis, MD, specializes in internal medicine. She is affiliated with UPMC Mercy. Dr. Vasilakis completed her residency at the University of Pittsburgh School of Medicine and medical degree at West Virginia University School of Medicine. Dr. Vasilakis is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Plasmacytoma, Heart Tumor, Primary Amyloidosis, and Adult Immune Thrombocytopenia.

Nicoletta Machin, DO, specializes in benign hematology and is certified in internal medicine by the American Board of Internal Medicine. She has a special clinical and research interest in inherited bleeding disorders and women's health related to hematologic issues including those impacting pregnancy. She completed her medical degree at the University of New England College of Osteopathic Medicine, followed by a residency and fellowship at the University of Pittsburgh School of Medicine. She practices at the University of Pittsburgh Physicians, Department of Hematology-Oncology, and is affiliated with UPMC Magee-Womens Hospital, UPMC Shadyside, and UPMC Presbyterian. Dr. Machin is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Hemophilia A, Von Willebrand Disease (VWD), Hemophilia B, Hemophilic Arthropathy, and Hormone Replacement Therapy (HRT).

Ramasubramanian (“Ram”) Kalpatthi, MD, is Clinical Research Director of Pediatric Sickle Cell Research and Director of PHO Medical Student and Resident Education at UPMC Children's Hospital of Pittsburgh. He is also a Visiting Associate Professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology. He earned his medical degree from Thanjavur Medical College in Thanjavur, India. He completed a Residency at All India Institute of Medical Sciences and Lincoln Medical Center followed by a fellowship at Nationwide Children's Hospital. Dr. Kalpatthi is nationally recognized for his excellence in the clinical care, clinical research, program development and leadership in the field of pediatric hematology oncology with special emphasis on sickle cell disease (SCD) and immune thrombocytopenia (ITP). His other clinical interests include therapeutic apheresis, immune hematological disorders, neonatal hematology, benign hematological disorders, and childhood leukemia. Also, he is a favorite among medical students, residents, and fellows due to his passion for teaching, guiding, and mentoring future generation of physicians. He has mentored medical students, residents, and fellows in completing clinical research projects that have been published and/or presented at national conferences such as the American Society of Hematology (ASH), the American Society of Pediatric Hematology/Oncology (ASPHO) and Pediatric Academic Societies (PAS) meeting. Several of his mentees received outstanding abstract achievement awards for their work and most of his mentees have published their research in leading medical journals. View the full list of Dr. Kalpatthi’s publications on PubMed. Dr. Kalpatthi is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Splenectomy.

Frederico Xavier, MD, MS, is the associate clinical director for the Hemophilia Center of Western Pennsylvania and an associate professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board-certified in Pediatrics and in Pediatric Hematology/Oncology. Dr. Xavier completed his medical degree, pediatric residency, and fellowship training in Brazil. He then completed a pediatric residency in New York, pediatric hematology and oncology fellowship at St. Jude Children’s Hospital, and then a pediatric hemostasis fellowship at the Hospital for Sick Children in Toronto, Ontario, Canada. Dr. Xavier completed a master’s degree in clinical research at the Indiana University-Purdue University Indianapolis. He has published peer-reviewed articles and book chapters in the field of pediatric hemostasis and is currently awarded with a research grant to study inflammation in Hemophilia. Dr. Xavier also sits in the Newborn Screening and Follow-up Technical Advisory Board for the Pennsylvania Department of Health. Dr. Xavier also practices at the Hemophilia Center of Western Pennsylvania, a state and federally-funded 501(c)3 charitable organization that provides comprehensive medical care to the residents of Western Pennsylvania with hemophilia and other bleeding and clotting disorders. The functions of the center include diagnosis and evaluation of individuals with bleeding disorders; treatment of bleeding episodes and complications; education of the patient and family, the community, and other medical providers; communication and advocacy; supervision of home care; and research and data collection. View the full list of Dr. Xavier’s publications on PubMed. Dr. Xavier is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Hemophilia A, Hemophilic Arthropathy, Hemophilia B, and Von Willebrand Disease (VWD).

View the full list of Dr. Friehling's publications on PubMed. Dr. Friehling is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Acquired Amegakaryocytic Thrombocytopenia, Chromosome 7p Deletion, Leukemia, and Juvenile Myelomonocytic Leukemia (JMML).

Cheryl A. Hillery, MD, is clinical director of Hematology at UPMC Children’s Hospital of Pittsburgh and a professor of Pediatrics within the Division of Hematology-Oncology at the University of Pittsburgh School of Medicine. She is the director of the Pediatric Comprehensive Sickle Cell Program and has led basic, translational, and clinical research studies focused on sickle cell disease. Dr. Hillery is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

James Cooper, MD, MSc, is clinical director of the Coagulation Program at UPMC Children's Hospital of Pittsburgh. He is also an assistant professor of pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology and pediatrics. Dr. Cooper earned his medical degree from University of Connecticut School of Medicine. He completed a residency and internship in pediatrics at the University of Connecticut-Connecticut Children's Medical Center followed by a fellowship in pediatric hematology-oncology at UPMC Children's Hospital. Dr. Cooper also earned his master's of science in clinical research at the University of Pittsburgh Institute for Clinical Research Education. In his role as clinical director of the Coagulation Program, Dr. Cooper cares for children with bleeding disorders and thrombosis concerns. As part of that mission, Dr. Cooper and Dr. Tahniat Syed of Adolescent Medicine co-lead a dedicated clinic for young women with menstrual disorders, known as the CHAMP (Comprehensive Hematologic Assessment of Adolescents with Menstrual Problems) Clinic. In addition to coagulation disorders, Dr. Cooper also cares for children with a variety of oncologic and other hematologic problems. Dr. Cooper’s research interests include thrombosis rates in adolescents and young adults versus younger children with cancer and the cost effectiveness of laboratory analysis of clotting disorders in children. He is a member of the American Society of Pediatric Hematology and Oncology, the American Society of Hematology, the Children’s Oncology Group, the Critical Mass Young Adult Alliance, the American Thrombosis & Hemostasis Network, the American Academy of Pediatrics, the Foundation for Women and Girls with Bleeding Disorders, and the Hemostasis and Thrombosis Research Society. View the full list of Dr. Cooper’s publications on PubMed. Dr. Cooper is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Mesenteric Venous Thrombosis, Venous Thromboembolism (VTE), Hemophilia A, and Blood Clots.

View the full list of Dr. Rapkin's publications on PubMed. Dr. Rapkin is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Rhabdoid Tumor, Non-Langerhans-Cell Histiocytosis, and Histiocytosis.

Paulina Horvei, MD, is board-certified in pediatric hematology-oncology and pediatrics by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh. Dr. Horvei received her medical degree from the University of Chile and completed her residency at Icahn School of Medicine at Mount Sinai, followed by fellowships at Mayo Clinic College of Medicine and Science and the University of California San Francisco School of Medicine. . Her top areas of expertise are Alpha Thalassemia, Systemic Sclerosis (SSc), Thalassemia, and Immune Thrombocytopenic Purpura (ITP).

Paul Szabolcs, MD, received his medical degree summa cum laude at the Semmelweis University School of Medicine in Budapest, Hungary. He completed his training in pediatrics at Bellevue Hospital/NYU Medical Center and subsequently trained in hematology/oncology at the Memorial Sloan Kettering Cancer Center/Cornell-NY Hospital Medical Center in New York City. He received postdoctoral laboratory training at the Memorial Sloan Kettering Cancer Center and at Rockefeller University in the Department of Physiology and Cellular Immunology. . His top areas of expertise are Graft Versus Host Disease (GvHD), Severe Combined Immunodeficiency (SCID), Leukemia, Systemic Sclerosis (SSc), and Bone Marrow Transplant.

Archana Ramgopal, DO, specializes in pediatric cellular therapy and is board-certified by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh. Dr. Ramgopal received her medical degree from Lake Erie College of Osteopathic Medicine and completed her residency at Cleveland Clinic, followed by a fellowship at the University of Pittsburgh School of Medicine. . Her top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Saddle Pulmonary Embolism, Beta Thalassemia, and Bone Marrow Transplant.

James Felker, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is assistant professor of medicine at the University of Pittsburgh School of Medicine. Dr. Felker received his medical degree from New York Medical College and completed his residency at Northwestern University/Ann & Robert H. Lurie Children’s Hospital of Chicago followed by a fellowship in pediatric hematology/oncology and neuro-oncology at Emory University/Children’s Healthcare of Atlanta, Ga. Dr. Felker’s clinical interests include pediatric brain and spinal tumors and clinical trial development. He has published numerous articles in peer-reviewed journals and is a member of the American Society of Pediatric Hematology/Oncology, American Society of Clinical Oncology, Society for Neuro-Oncology, Children’s Oncology Group, and the Pediatric Brain Tumor Consortium. His wife is a pediatric cardiologist at UPMC Children’s and has an interest in long term cardiac outcomes for oncology patients. Together they have two girls and a beagle mutt. Dr Felker enjoys running along the rivers in Pittsburgh while trying to avoid the hills. View the full list of Dr. Felker's publications on PubMed. View Dr. Felker's profile at the University of Pittsburgh School of Medicine – Department of Pediatrics. LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling. . His top areas of expertise are Brain Stem Cancer, Glioma, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma.

Scott Maurer, MD, is a pediatric palliative care physician and a pediatric oncologist. Dr. Maurer is certified in pediatrics, pediatric hematology/oncology, and hospice and palliative medicine by the American Board of Pediatrics. He is the chief of the division of palliative medicine and supportive care at UPMC Children’s Hospital of Pittsburgh and is an associate professor of pediatrics at the University of Pittsburgh School of Medicine. . His top areas of expertise are Infantile Neutropenia, Rosai-Dorfman Disease, Leukemia, and Pediatric Low-Grade Glioma (pLGG).

Jenny Ruiz, MD, specializes in pediatric hematology oncology and is board certified in pediatric hematology-oncology and pediatrics by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh, Pediatric Hematology/Oncology and is affiliated with UPMC Magee-Womens Hospital. Dr. Ruiz completed her fellowship at Children's Hospital of Philadelphia, residency at Columbia University, and medical education at Columbia University College of Physicians and Surgeons. . Her top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), Ewing Sarcoma, and Osteosarcoma.

Lisa Maurer, MD, PhD, is a pediatric oncologist with an interest in pediatric leukemia and lymphoma. She is also a physician-scientist in the Lucas/ McAllister Lab in the Rangos Research Center of the UPMC Children's Hospital of Pittsburgh. Currently, Dr. Maurer's research focus is on the role of GRK2 in inhibition of the MALT1 proto-oncoprotein in lymphomagenesis. Dr. Maurer earned her medical degree from University of Wisconsin School of Medicine and Public Health and her PhD from the University of Wisconsin-Madison. She completed an internship and residency at the University of California San Francisco followed by a fellowship at UPMC Children’s Hospital of Pittsburgh. She is a member of the American Society of Pediatric Hematology Oncology and the AACR. View the full list of Dr. Maurer’s publications on PubMed. . Her top areas of expertise are Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, and Embryonal Tumor with Multilayered Rosettes.

Randy Windreich, MD, is a pediatric bone marrow transplant specialist and is board-certified in pediatrics and pediatric hematology-oncology by the American Board of Pediatrics. He is clinical director of the Division of Blood and Marrow Transplantation and Cellular Therapy at UPMC Children’s Hospital of Pittsburgh and associate professor of pediatrics at the University of Pittsburgh School of Medicine. . His top areas of expertise are Graft Versus Host Disease (GvHD), Infantile Neutropenia, Beta-Mannosidosis, Chediak-Higashi Syndrome, and Bone Marrow Transplant.

Julia Meade, MD, is a pediatric genetic oncologist certified in pediatric hematology/oncology by the American Board of Pediatrics. She is an Associate Professor of Pediatrics at the University of Pittsburgh School of Medicine in both the divisions of Pediatric Hematology/Oncology and Genetic and Genomic Medicine. Dr. Meade holds a secondary appointment as Associate Professor of Human Genetics in the School of Public Health. She received her medical degree from Texas A&M University School of Medicine and completed her pediatric residency at the University of Colorado, followed by her hematology/oncology fellowship at UT Southwestern Medical Center and her pediatric neuro-oncology fellowship at Northwestern University. Dr. Meade also holds a certificate in cancer risk assessment from the City of Hope. . Her top areas of expertise are Ewing Sarcoma, L1 Syndrome, Osteosarcoma, and Medulloblastoma.

View the full list of Dr. Bukowinski's publications on PubMed. . His top areas of expertise are Adult Soft Tissue Sarcoma, Leukemia, Rhabdomyosarcoma, and Osteosarcoma.